Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice-Reference-Cited by-同舟云学术

Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice

Published:2016-02 Issue:7 Volume:34 Page:923-932
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Backes Simone,Jäger Clemens,Dembek Claudia J.,Kosinska Anna D.,Bauer Tanja,Stephan Ann-Sophie,Dišlers Andris,Mutwiri George,Busch Dirk H.,Babiuk Lorne A.,Gasteiger Georg,Protzer Ulrike

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference39 articles.

1. Immunology of hepatitis B virus and hepatitis C virus infection;Rehermann;Nat Rev Immunol,2005

2. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor;Ilan;Gastroenterology,1993

3. Design of therapeutic vaccines: hepatitis B as an example;Kutscher;Microb Biotechnol,2012

4. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges;Michel;J Hepatol,2011

5. High-level hepatitis B virus replication in transgenic mice;Guidotti;J Virol,1995

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection;Nature;2024-07-10

2. The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor Hepatitis B Virus clearance in mice;Antiviral Research;2024-06

3. Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component;JHEP Reports;2023-12

4. IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B;Hepatology Communications;2023-12

5. What Is the Current Status of Hepatitis B Virus Viro-Immunology?;Clinics in Liver Disease;2023-11